• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

    6/21/22 7:52:33 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $YCBD alert in real time by email
    SC 13D/A 1 ycbd_sc13da.htm SC 13D/A ycbd_sc13da.htm

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C.  20549

     

    SCHEDULE 13D/A

     

    Under the Securities Exchange Act of 1934 (Amendment No. 9)*

     

    cbdMD, Inc.

    (Name of Issuer)

     

    common stock

    (Title of Class of Securities)

     

    12482W101

    (CUSIP Number)

     

    Mr. R. Scott Coffman

    c/o 8845 Red Oak Boulevard

    Charlotte, NC  28217

    (704) 445-3060

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    June 20, 2022

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is subject to this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. ☐

     

    *          The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (“Act”) or other subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.)

     

     

     

       

    (1)

    NAMES OF REPORTING PERSONS

    R. Scott Coffman

     

    (2)

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

    (a)  ☐

    (b)  ☐

    (3)

    SEC USE ONLY

     

     

     

     

    (4)

    SOURCE OF FUNDS (see instructions)

    WC

     

    (5)

    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

     

    ☐

     

     

    (6)

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

     

     

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

    (7)

    SOLE VOTING POWER

     

    15,295,812 shares

     

     

    (8)

    SHARED VOTING POWER

     

    0 shares

     

     

    (9)

    SOLE DISPOSITIVE POWER

     

    16,731,906 shares

     

     

    (10)

    SHARED DISPOSITIVE POWER

     

    0 shares

     

     

     

    (11)

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    16,731,906 shares (1)

     

     

    (12)

    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

     

    ☐

     

     

    (13)

    PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    27.8% (2)

     

     

    (14)

    TYPE OF REPORTING PERSON (See Instructions)

    IN

     

     

     

    (1)

    Represents (a) outstanding shares of the Issuer’s common stock over which the Reporting Person has dispositive control, and (b) 140,000 shares of the Issuer’s common stock underlying vested stock options. See Item 5.

     

     

    (2)

    Based on 59,941,090 shares of common stock outstanding as of May 17, 2022.
     
     
    Page 2 of 4

     

     

    Item 1. Security and Issuer.

     

    This Schedule 13D relates to the common stock, par value $0.001 per share, of cbdMD, Inc., a North Carolina corporation (the “Issuer”). The Issuer's principal executive offices are located at 8845 Red Oak Boulevard, Charlotte, NC 28217.

     

    Item 2. Identity and Background.

     

    The Reporting Person is R. Scott Coffman. The Reporting Person's business address is 8845 Red Oak Boulevard, Charlotte, NC 28217. The Reporting Person is a member of the Board of Directors of the Issuer.

     

    During the past five years the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) nor was the Reporting Person a party to a civil proceeding or a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoying future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     

    The Reporting Person is a U.S. citizen.

     

    Item 3. Source and Amount of Funds or Other Consideration.

     

    Working capital of the Reporting Person.

     

    Item 4. Purpose of Transaction.

     

    All of the Issuer’s securities owned by the Reporting Person were acquired for investment purposes only and are being held as a long-term investments. The Reporting Person does not have any current plans or proposals which relate to or would result in any matters set forth in Items 4(a) through 4(j) of Schedule 13D.

     

    Item 5. Interest in Securities of the Issuer.

     

    The number of outstanding shares of the Issuer's common stock beneficially owned by the Reporting Person includes:

     

     

    ·

    3,684,000 shares held of record by Edge of Business, LLC (“Edge of Business”);

     

    ·

    12,907,906 shares held of record by the Coffman Family Office, LLC (“Coffman Family Office”); and

     

    ·

    140,000 shares underlying vested stock options with an exercise price of $3.15 per share.
     

    The Reporting Person has voting and dispositive control over securities owned of record by Edge of Business.  Coffman Management, LLC (“Coffman Management”) is the Manager of Coffman Family Office and the Reporting Person is the Manager of Coffman Management.  Except as set forth in this Item 5, the Reporting Person has voting and dispositive control over securities owned of record by Coffman Family Office.  The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein.

     

    Of the 12,907,906 shares of common stock held of record by Coffman Family Office, the Reporting Person has the sole power to vote 11,471,812 shares. Included in the number of shares is 1,436,094 shares, which voting rights vested on June 20, 2022. The balance of 1,436,094 shares are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and Coffman Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer’s board of directors who will vote such shares on any matter brought before the Issuer’s shareholders in accordance with the recommendation of its board of directors. The voting rights to the 1,436,094 shares vest on December 20, 2023.

     

    The number of outstanding shares of the Issuer’s common stock beneficially owned by the Reporting Person excludes Earnout Rights to up to an additional 2,848,095 shares of the Issuer’s common stock.

     

    Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

     

    The information appearing in Item 5 is incorporated by reference into this Item 6.

     

    Item 7. Material to be Filed as Exhibits.

     

    None.

     

     
    Page 3 of 4

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.

     

     Date: June 21, 2022

    /s/ R. Scott Coffman

     

     

    R. Scott Coffman

     

     

     
    Page 4 of 4

     

    Get the next $YCBD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $YCBD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $YCBD
    Leadership Updates

    Live Leadership Updates

    See more
    • cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

      Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs and emerging THC-infused seltzer brand Herbal Oasis announced today that at the Company's annual meeting of shareholders held on April 10, 2025, that its Common Stock holders and 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") holders approved the automatic conversion (the "Conversion") of shares of the Company's Preferred Stock into shares of the Comp

      4/10/25 5:57:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega

      Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE:YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency.As a brand that's renowned for its commitment to quality and innovation, cbdMD's comprehensive line of products spans across various categories and caters to a diverse range of consumer needs. By partnering with Dr. Vega, a highly qualified and passi

      6/22/23 9:00:00 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD Welcomes Shannon Charles as Chief Marketing Officer

      Charlotte, North Carolina--(Newsfile Corp. - January 11, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the appointment of Shannon Charles as Chief Marketing Officer. Shannon is a veteran in health and wellness with over a decade of success in the Natural Product Industry. She has a proven record in driving growth across B&M retail, warehouse club stores, ecommerce, as well as international markets. Shannon's leadership has supported the successful brand stories of Naturade, NeoCell, and NutraNext, which the latter was ultimately acquired by The Clorox Co during her tenure. "We are thrilled to h

      1/11/23 12:33:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    SEC Filings

    See more
    • cbdMD Inc. filed SEC Form 8-K: Other Events

      8-K - cbdMD, Inc. (0001644903) (Filer)

      5/20/25 5:19:59 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 10-Q filed by cbdMD Inc.

      10-Q - cbdMD, Inc. (0001644903) (Filer)

      5/15/25 4:07:09 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SCHEDULE 13D filed by cbdMD Inc.

      SCHEDULE 13D - cbdMD, Inc. (0001644903) (Subject)

      5/8/25 4:02:08 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cantor Fitzgerald resumed coverage on cbdMD with a new price target

      Cantor Fitzgerald resumed coverage of cbdMD with a rating of Neutral and set a new price target of $3.25 from $4.10 previously

      6/18/21 6:26:36 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Cantor Fitzgerald reiterated coverage on cbdMD with a new price target

      Cantor Fitzgerald reiterated coverage of cbdMD with a rating of Neutral and set a new price target of $4.30 from $3.60 previously

      1/29/21 4:54:10 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia

      Charlotte, North Carolina--(Newsfile Corp. - May 21, 2025) - Herbal Oasis ("Oasis"), the hemp-derived THC-infused social seltzer redefining how people connect, unwind, and celebrate life, is proud to announce a new distribution partnership with Beverage South, a leading distributor serving much of the state of Georgia. Starting this month, Oasis will be available on shelves across Georgia as the brand continues its rapid expansion across the Southeast.Georgia marks the fourth state in just two months where Oasis has launched, following successful rollouts in Alabama, Florida, and North Carolina. The partnership with Beverage South significantly strengthens Oasis's presence in one of the regi

      5/21/25 7:00:00 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

      Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter of fiscal year ended September 30, 2025. The Company reported continued year-over-year improvements in both revenue and earnings while completing a transformative restructuring of its capital structure.The Company delivered $4.8 million in revenue for the second quarter, up from $4.3 million in the prior year peri

      5/15/25 4:09:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

      Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, May 15, 2025, 4:20 p.m. Eastern Time USA/Canada:833-821-3524  International:647-846-2919  Teleconference Replay dial in: USA/Canada:855-669-9658  International:412-317-0088  Replay Passcode:7254091  Webcast/Webcast Replay link - available through May 15, 2026: https://www.gowebc

      5/9/25 12:57:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Porter Jeffrey H was granted 1,572 shares (SEC Form 4)

      4 - cbdMD, Inc. (0001644903) (Issuer)

      5/20/25 5:23:40 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Raines William F Iii was granted 1,572 shares, increasing direct ownership by 15% to 12,104 units (SEC Form 4)

      4 - cbdMD, Inc. (0001644903) (Issuer)

      5/20/25 5:23:18 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Roe Kevin Charles was granted 1,572 shares, increasing direct ownership by 7% to 25,135 units (SEC Form 4)

      4 - cbdMD, Inc. (0001644903) (Issuer)

      5/20/25 5:22:53 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

      SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

      8/12/22 4:02:14 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

      SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

      6/21/22 7:52:33 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

      SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

      5/19/22 4:05:28 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    Financials

    Live finance-specific insights

    See more
    • cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

      Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter of fiscal year ended September 30, 2025. The Company reported continued year-over-year improvements in both revenue and earnings while completing a transformative restructuring of its capital structure.The Company delivered $4.8 million in revenue for the second quarter, up from $4.3 million in the prior year peri

      5/15/25 4:09:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

      Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, May 15, 2025, 4:20 p.m. Eastern Time USA/Canada:833-821-3524  International:647-846-2919  Teleconference Replay dial in: USA/Canada:855-669-9658  International:412-317-0088  Replay Passcode:7254091  Webcast/Webcast Replay link - available through May 15, 2026: https://www.gowebc

      5/9/25 12:57:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD Generates $5.1 Million in Revenue, Positive Earnings

      Charlotte, North Carolina--(Newsfile Corp. - February 13, 2025) - (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the first quarter of fiscal year ended December 31, 2024. The Company started fiscal 2025 with a historic quarter, achieving sequential revenue growth, positive net income and, although a loss from operations, the first ever quarter of positive non-GAAP Adjusted EBITDA. The Company generated Net Income of $15,000, an approximate $1 million improvement from the prior

      2/13/25 4:10:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary